Found: 2
Select item for more details and to access through your institution.
Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 7, p. 3082, doi. 10.1210/jc.2002-021545
- By:
- Publication type:
- Article
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article